| Dr John M Winterton, MD | |
|
1717 Oak Park Blvd, Second Floor, Lake Charles, LA 70601-8991 | |
| (337) 494-3278 | |
| (337) 494-3240 |
| Full Name | Dr John M Winterton |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 34 Years |
| Location | 1717 Oak Park Blvd, Lake Charles, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114018819 | NPI | - | NPPES |
| 1915840 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 20942 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Willis Knighton Medical Center, Inc | Shreveport, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wk Pierremont Cardiology | 0547571499 | 20 |
News Archive
New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson's disease and multiple sclerosis.
The results of a new study to be published in the Canadian Medical Association Journal show that COLD-fX, an anti-flu, anti-cold pill, reduced the incidence and frequency of recurrent colds by more than half. It also cut the duration of colds and significantly reduced their severity.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 9 to 5 that the available data do not adequately demonstrate that the potential benefits of lorcaserin outweigh the potential risks, when used long-term in a population of overweight and obese individuals to allow marketing approval.
› Verified 7 days ago
| Entity Name | Wk Pierremont Cardiology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235523002 PECOS PAC ID: 0547571499 Enrollment ID: O20150618000783 |
News Archive
New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson's disease and multiple sclerosis.
The results of a new study to be published in the Canadian Medical Association Journal show that COLD-fX, an anti-flu, anti-cold pill, reduced the incidence and frequency of recurrent colds by more than half. It also cut the duration of colds and significantly reduced their severity.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 9 to 5 that the available data do not adequately demonstrate that the potential benefits of lorcaserin outweigh the potential risks, when used long-term in a population of overweight and obese individuals to allow marketing approval.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John M Winterton, MD 1717 Oak Park Blvd, Second Floor, Lake Charles, LA 70601-8991 Ph: (337) 494-3278 | Dr John M Winterton, MD 1717 Oak Park Blvd, Second Floor, Lake Charles, LA 70601-8991 Ph: (337) 494-3278 |
News Archive
New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson's disease and multiple sclerosis.
The results of a new study to be published in the Canadian Medical Association Journal show that COLD-fX, an anti-flu, anti-cold pill, reduced the incidence and frequency of recurrent colds by more than half. It also cut the duration of colds and significantly reduced their severity.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 9 to 5 that the available data do not adequately demonstrate that the potential benefits of lorcaserin outweigh the potential risks, when used long-term in a population of overweight and obese individuals to allow marketing approval.
› Verified 7 days ago
Robin Ann Rougeau, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 555 South Ryan St, #101, Lake Charles, LA 70601 Phone: 337-439-0762 Fax: 337-436-8862 | |
Dr. Jean King White, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1717 Oak Park Blvd Fl 2, Lake Charles, LA 70601 Phone: 337-494-3278 Fax: 337-494-3240 | |
Dr. William R Condos Jr., M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1717 Oak Park Blvd, Fl 2, Lake Charles, LA 70601 Phone: 337-494-3278 Fax: 337-494-3240 | |
Dr. Leroy E Fredericks, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2770 3rd Ave Ste 210, Lake Charles, LA 70601 Phone: 337-494-6768 Fax: 337-494-6792 | |
Gerald W Byrd, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 501 Dr Michael Debakey Dr, Lake Charles, LA 70601 Phone: 337-433-8400 Fax: 337-433-7350 | |
Hari Bogabathina, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1717 Oak Park Blvd Fl 2, Lake Charles, LA 70601 Phone: 337-494-3278 Fax: 337-494-3240 | |
Dr. Eric Charles Fontenot, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2770 3rd Ave Ste 345, Lake Charles, LA 70601 Phone: 337-494-4785 Fax: 337-494-4786 |